Teleflex Inc (Teleflex) designs, manufactures, and commercializes medical devices for critical care and surgical applications.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Teleflex focuses on the development of novel and innovative products and enhancement of the clinical value, ease of use, and safety and reliability of its existing product lines. It aims to develop innovative methods and devices to reduce infection risks, improve patient and clinician safety, enhance patient outcomes and enable less invasive procedures. The company has an array of patented products including Angio Assist Docking Station; Expro Elite Snare; EZPlaz Freeze Dried Plasma; Gel-Bead Embolization Spheres; Guardian Hemostasis Valve; GuideLiner catheters; Intra-Aortic Balloon Pumps; AutoCAT2WAVE(r) IABP; AutoCAT(r) 2 IABP. In FY2022, the company spent US$153.8 million on R&D activities, which as a percentage of revenue stood at 5.5%, and grew 17.6% YoY.